ArticleCancers2021

A Single-Run Next-Generation Sequencing (NGS) Assay for the Simultaneous Detection of Both Gene Mutations and Large Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes (MDS) and Related Myeloid Neoplasms.

Alessandro Liquori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.